RMR Wealth Builders’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.89M Buy
7,409
+1,389
+23% +$1.42M 0.55% 31
2026
Q1
$5.54M Buy
6,020
+416
+7% +$422K 0.44% 36
2025
Q4
$6.02M Buy
5,604
+302
+6% +$289K 0.48% 33
2025
Q3
$4.05M Buy
5,302
+108
+2% +$80.4K 0.34% 41
2025
Q2
$4.05M Buy
5,194
+277
+6% +$215K 0.37% 37
2025
Q1
$4.06M Buy
4,917
+231
+5% +$192K 0.43% 35
2024
Q4
$3.62M Buy
4,686
+107
+2% +$88.6K 0.37% 35
2024
Q3
$4.06M Buy
4,579
+113
+3% +$102K 0.43% 33
2024
Q2
$4.04M Buy
4,466
+294
+7% +$235K 0.46% 32
2024
Q1
$3.25M Buy
4,172
+650
+18% +$463K 0.39% 37
2023
Q4
$2.05M Buy
3,522
+364
+12% +$212K 0.29% 44
2023
Q3
$1.7M Buy
3,158
+1,118
+55% +$576K 0.27% 45
2023
Q2
$957K Buy
2,040
+867
+74% +$364K 0.16% 64
2023
Q1
$403K Buy
1,173
+5
+0.4% +$1.69K 0.08% 129
2022
Q4
$427K Buy
1,168
+465
+66% +$165K 0.1% 110
2022
Q3
$227K Buy
703
+76
+12% +$24.1K 0.06% 169
2022
Q2
$203K Buy
+627
New +$188K 0.05% 187
2021
Q2
Sell
-1,353
Closed -$253K 456
2021
Q1
$253K Buy
+1,353
New +$265K 0.07% 157
2020
Q4
Sell
-1,399
Closed -$207K 539
2020
Q3
$207K Buy
+1,399
New +$217K 0.05% 195

Other funds holding LLY

RMR Wealth Builders's LLY Position: Q2 2026 in Review

RMR Wealth Builders increased its Eli Lilly (LLY) stake by 23% in Q2 2026, buying an estimated $1.42M and bringing the position to 7,409 shares worth $8.89M. The position accounts for 0.55% of the portfolio, ranked #31.

RMR Wealth Builders first reported a position in LLY in Q3 2020 and has held it in 19 quarters since. 1,649 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • RMR Wealth Builders held 7,409 shares of Eli Lilly worth $8.89M as of Q2 2026.
  • RMR Wealth Builders bought 1,389 Eli Lilly shares in Q2 2026, an estimated $1.42M.
  • Eli Lilly made up 0.55% of RMR Wealth Builders's portfolio in Q2 2026, its #31 holding.
  • RMR Wealth Builders first reported a position in Eli Lilly in Q3 2020 and has held it in 19 quarters since.
  • 1,649 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on RMR Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.